MYND Life Sciences Inc. is a clinical-stage life sciences company focused on developing and commercializing drug therapies, along with a proprietary biomarker test, to diagnose and monitor the ...

The single-cell and spatial biology company reported quarterly sales of $165.02 million, down 10% year over year, beating the consensus of $159.39 million. Gross margin was 67% for the fourth ...

10x Genomics posted a Q4 EPS loss of $(0.40), missing the $(0.30) estimate. The company’s 2025 sales guidance of $610M-$630M is below the $631.14M consensus. Get two weeks of free access to pro ...

The internet erupted in controversy over Felisa Wolfe-Simon and colleagues’ claim of a microbe thriving on arsenic. Nearly 15 ...

Leaders look to capitalize on South Carolina's standing as the sixth-fastest state for growth in life sciences in the U.S.

Other large investors have also made changes to their positions in the company. Mirae Asset Global Investments Co. Ltd. raised its stake in Wave Life Sciences by 23.4% during the 3rd quarter.

Mark Zuckerberg is taking a break from expanding the Metaverse to instead expand his real-world foundation’s footprint in ...

ISG has launched a study examining service providers offering industry-specific expertise and technology support to life sciences companies worldwide.

a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, has integrated data from the UK interactive Costing Tool (iCT), hosted by the National ...

The company best known for its Cologuard colon cancer screening test posted a loss of $864.6 million, or $4.67 per share, on ...

WILMINGTON, N.C. (WECT) - A new science sector is coming to the Wilmington International Airport (ILM). Frontier Scientific Solutions announced the construction of a cGMP temperature-controlled ...